Stay updated on Efficacy of Losmapimod in FSHD Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Losmapimod in FSHD Clinical Trial page.

Latest updates to the Efficacy of Losmapimod in FSHD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page displays the completed Phase 2 losmapimod study record for facioscapulohumeral muscular dystrophy, including its design, participant criteria, outcome measures, publications, and supporting documents.SummaryDifference68%

- Check17 days agoChange DetectedThe site footer now identifies the release as v3.8.0 instead of v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA notice announces NIH website updates and explains that NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe footer's site revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now shows a 403 Forbidden error for the study URL, replacing the normal study record content. It displays a minimal header with a Home link and a revision note, indicating the study is temporarily inaccessible.SummaryDifference20%

Stay in the know with updates to Efficacy of Losmapimod in FSHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Losmapimod in FSHD Clinical Trial page.